Skip to main content

Table 1 Characteristics of EU-Meds Study, 2014

From: Nonmedical use of prescription drugs in the European Union

Characteristic

Percentagea

Total No.b

Country

  

 Denmark

12.4

2,732

 Germany

24.9

5,511

 Great Britain

25.3

5,572

 Spain

24.9

5,507

 Sweden

12.5

2,748

Sex

  

 Male

50.3

9,725

 Female

49.7

12,245

Race

  

 White

93.0

17,475

 Non-white

7.0

1,413

Age, years

  

 12–17

9.2

2,032

 18–29

32.9

7,048

 30–49

57.9

12,990

Marital Statusc

  

 Never married

45.5

8,775

 Married/cohabitating

33.2

7,032

 Divorced/separated/widowed

21.3

4,231

Employment

  

 Full/Part time

52.5

12,133

 Unemployed

11.2

2,268

 Student

18.4

3,950

 Not in labor force

17.9

3,719

Lifetime NMPDU

  

 Stimulant

7.0

1,302

 Opioid

13.5

2,682

 Sedative

10.9

2,203

Past-Year NMPDU

  

 Stimulant

2.8

498

 Opioid

5.0

949

 Sedative

5.8

1,099

Illicit Drug Use, Lifetimed

38.1

7,856

Illicit Drug Use, Past-Yeard

11.7

2,200

  1. NMPDU nonmedical prescription drug use
  2. aEstimate based on weighted data
  3. bSample size is unweighted
  4. cSample restricted to ages 18 or older
  5. dIllicit drug use includes marijuana, cocaine, heroin, methamphetamine, hallucinogens, inhalants, and designer drugs